Scotiaderm Inc.
$138,800.00 CAD
≈ 22 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2024-2025
- Agreement period
- June 1, 2024 – January 4, 2027
- Reference
- nrc-cnrc:172-2024-2025-Q2-1020205
Published purpose
Three studies will be conducted; study 1 is a pilot that aims to de-risk studies 2 and 3 by validating a novel monitoring tool, the IAD-ITD-M, for nurses to assess and track moisture-associated skin damage (MASD) caused by incontinence, distinguishing it from other conditions. Studies 2 and 3 evaluate the safety and efficacy of a proprietary cream (DermaShield) – containing a natural plant extract - in treating MASD from diarrhea or fecal incontinence, hypothesizing improved healing compared to the standard of care.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions